News you can use: health & drug safety updates


  • August 1, 2015

    APhA Pharmacy Today

  • July 28, 2015
    Women face unique issues when it comes to substance use, both biological (sex) and cultural (gender). This new online resource by the National Institute on Drug Abuse (NIDA), provides information on the importance of scientific research into sex and gender issues related to drug use. It includes research summaries about women and commonly abused drugs, including marijuana and prescription medications. Additionally, this new web section summarizes the latest research related to drug use while pregnant or breastfeeding, along with what science has
  • July 24, 2015
    The FDA will examine how pharmaceutical manufacturers’ effectiveness claims in direct-to-consumer prescription drug advertising affect consumer beliefs about medication quality. In a two-part study, OPDP will survey patients with diabetes using nine different mock print ads with varying levels of efficacy information. Researchers will then test respondents to gauge their memory, perception and understanding of the drug risks and benefits.
  • July 23, 2015
    More than 10 million youth aged 12-17 in the United States are either open to trying smoking or are already experimenting with cigarettes—meaning they have tried fewer than 100 cigarettes in their lifetime. In fact, every day in the United States, nearly 2,900 youth under age 18 smoke their first cigarette—and more than 700 youth under age 18 become daily cigarette smokers. FDA’s first youth tobacco prevention campaign, “The Real Cost,” launched in February 2014 and continues to reach
  • July 23, 2015
    The July issue of CDC’s Vital Signs addresses changing trends and risk factors for heroin use in the United States. This Vital Signs highlights significant increases in heroin use, abuse, and dependence among a wider range of demographic groups that have not been seen before. In addition, these increases parallel the sharp rise in heroin overdose deaths seen in the past decade. The information contained in the Vital Signs provides critical new insight that can help to better tailor prevention efforts. Key points in the Vital Signs report include:
  • July 20, 2015
    A proposal announced at the White House Conference on Aging would make major changes to improve the care and safety of the nearly 1.5 million residents in the more than 15,000 long-term care facilities or nursing homes that participate in the Medicare and Medicaid programs. If finalized, unnecessary hospital readmissions and infections would be reduced, quality care increased, and safety measures strengthened for the more than one million residents in these facilities. One of the many proposed changes includes updating the nursing home’s infection
  • July 16, 2015
    The next National Prescription Drug Take-Back Day will be held on September 26 from 10 a.m. to 2 p.m., the Drug Enforcement Administration (DEA) has announced. The National Prescription Drug Take-Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications. Collection sites will be announced on September 1, the DEA said. During the ninth Prescription Drug Take-Back Day last September, DEA and its partners collected 209 tons of pills.
  • July 9, 2015
    The Food and Drug Administration (FDA) is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on our comprehensive review of new safety information, we are requiring updates to the drug labels of all prescription NSAIDs. As is the case with current prescription NSAID labels, the Drug Facts labels of over-the-counter (OTC) non-aspirin NSAIDs already contain information on heart attack and stroke risk. We will also request updates to the OTC non-aspirin
  • July 8, 2015
    Here are 10 types of medications that can cause insomnia. If you are taking any of them and having sleep problems, you should talk with your doctor or pharmacist about adjusting the dosage, changing to another type of medication, or trying an alternative treatment or therapy. 1. Alpha-blockers 2. Beta-blockers 3. Corticosteroids 4. SSRI antidepressants 5. ACE inhibitors 6. ARBs 7. Cholinesterase inhibitors 8. H1 antagonists 9. Glucosamine/chondroitin 10. Statins (Source: AARP)
  • July 7, 2015
    FDA wants to make sure that the next time your child has ear pain requiring a prescription drug, the product has been approved by FDA as safe and effective. That’s why FDA is notifying companies to stop marketing 16 unapproved prescription drugs labeled to relieve ear pain and swelling. These ear drops contain active ingredients such as benzocaine and hydrocortisone but have not been evaluated by FDA for safety, effectiveness and quality. For years, health care providers have prescribed—and